Allgens(SH:688613)2021-10-28 16:00Financial Performance - The company's operating revenue for Q3 2021 was ¥63,519,297.92, representing a year-on-year increase of 4.8%[5] - The net profit attributable to shareholders for the same period was ¥37,727,200.89, up 4.26% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 15.03% to ¥32,368,919.01[5] - The basic earnings per share for Q3 2021 was ¥0.29, a decrease of 18.76% year-on-year[6] - The weighted average return on equity was 5.25%, a decrease of 1.20 percentage points compared to the previous year[6] - Net profit for the third quarter of 2021 was ¥82,806,965.92, representing an increase of 83.8% from ¥45,067,402.12 in the same quarter of 2020[23] - The net profit attributable to shareholders of the parent company for Q3 2021 was approximately ¥85.01 million, compared to ¥46.21 million in Q3 2020, representing an increase of 83.9%[24] - The total comprehensive income attributable to shareholders of the parent company for Q3 2021 was approximately ¥85.02 million, compared to ¥46.25 million in Q3 2020, an increase of 83.8%[24] Revenue Growth - The increase in operating revenue year-to-date by 51.36% was attributed to effective control of the domestic pandemic and increased market promotion activities[10] - Total revenue for the first three quarters of 2021 reached ¥154,753,320.07, a 51.3% increase compared to ¥102,245,191.82 in the same period of 2020[22] - The revenue from bone products increased by 62.50% compared to the same period last year[11] - The revenue from cranial products grew by 18.70% year-over-year[11] - The revenue from dental products surged by 83.01% compared to the previous year[11] Cash Flow and Assets - Cash flow from operating activities for the year-to-date was ¥94,752,205.17, reflecting a significant increase of 203.86%[6] - The net cash flow from operating activities for the first three quarters of 2021 was approximately ¥94.75 million, significantly higher than ¥31.18 million in the same period of 2020, marking an increase of 203.5%[27] - Total cash inflow from operating activities for the first three quarters of 2021 was approximately ¥228.16 million, compared to ¥116.34 million in the previous year, indicating a growth of 96.1%[26] - The total assets at the end of the reporting period reached ¥1,386,712,365.48, an increase of 72.28% compared to the end of the previous year[6] - The total assets as of the end of the third quarter of 2021 were ¥1,386,712,365.48, compared to ¥804,931,307.11 at the end of the same period in 2020, reflecting a growth of 72.2%[19] - The company's cash and cash equivalents stood at ¥453,822,849.81, an increase from ¥21,117,197.02 in the previous year[18] - The total cash and cash equivalents at the end of Q3 2021 were approximately ¥449.09 million, compared to ¥15.44 million at the end of Q3 2020, reflecting a substantial increase[27] Research and Development - Research and development expenses amounted to ¥8,906,169.97, accounting for 14.02% of operating revenue, an increase from 8.90% in the same period last year[6] - Research and development expenses for the third quarter of 2021 amounted to ¥20,178,941.73, which is a 100.5% increase from ¥10,068,954.87 in the previous year[23] - Research and development expenses totaled 100.41 million RMB, primarily due to an increase in R&D personnel and project costs[11] Equity and Liabilities - The company's total equity attributable to shareholders increased by 94.08% to ¥1,208,500,659.37 compared to the end of the previous year[6] - The total equity attributable to shareholders reached ¥1,208,500,659.37, up from ¥622,667,125.26 in the same period of 2020, marking a growth of 93.7%[20] - The total liabilities as of the end of the third quarter of 2021 were ¥151,399,020.27, a slight decrease from ¥153,246,510.15 in the previous year[20] Financing Activities - The net cash flow from financing activities for Q3 2021 was approximately ¥489.47 million, a significant increase from ¥4.56 million in the same period last year[27] - The net cash flow from financing activities was 10,632.76 million RMB, resulting from funds raised during the company's IPO[11] Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[23]